Principia Biopharma Inc. Common Stock
PRNB
PRNB was delisted on the 25th of September, 2020.
81 hedge funds and large institutions have $569M invested in Principia Biopharma Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 7 closing their positions.
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
43% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 23
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
9% more funds holding
Funds holding: 74 → 81 (+7)
15% less capital invested
Capital invested by funds: $671M → $569M (-$102M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$20M |
| 2 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$10.3M |
| 3 |
BlackRock
New York
|
+$4.38M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.79M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$3.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NLVP
New Leaf Venture Partners
New York
|
-$23.1M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$22.8M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$4.91M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.67M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.46M |
PRNB Hedge Fund Activity: Q3 2019 in Review
81 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Principia Biopharma Inc. Common Stock (PRNB) for Q3 2019, worth a combined $569M — down 15% from $671M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new PRNB positions and 7 closed out — a net gain of 7 holders — while 33 added to existing stakes and 23 trimmed.
The largest buyer was Redmile Group, adding an estimated $20M. The largest seller was New Leaf Venture Partners, cutting an estimated $23.1M.
- 81 institutional investors held Principia Biopharma Inc. Common Stock (PRNB) as of Q3 2019, up from 74 in Q2 2019.
- Funds reported $569M of Principia Biopharma Inc. Common Stock stock for Q3 2019, down 15% quarter-over-quarter.
- 14 funds opened new Principia Biopharma Inc. Common Stock positions in Q3 2019 and 7 closed out, a net change of +7 holders.
- The largest Principia Biopharma Inc. Common Stock buyer in Q3 2019 was Redmile Group, an estimated $20M added.
- The largest Principia Biopharma Inc. Common Stock seller in Q3 2019 was New Leaf Venture Partners, an estimated $23.1M sold.
Based on aggregated 13F filings for Q3 2019.